Cigna vs NeoGenomics Laboratories, Inc.
Cigna (CI) and NeoGenomics Laboratories, Inc. (NEO) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $71.4B
- Last close
- $270.90
- 12 months
- +0.5%
- Market value
- $1.92B
- Last close
- $14.82
- 12 months
- +39.8%
At a glance
- The biggest part of NeoGenomics Laboratories, Inc.'s revenue is Client direct billing, 71% of the total in its last annual report.
- By market value, Cigna ($71.4B) is about 37 times NeoGenomics Laboratories, Inc. ($1.9B).
- Over the last 12 months Cigna's share price moved +0.5% and NeoGenomics Laboratories, Inc.'s +39.8%; against the S&P 500 that is −5.2 points and +34.1 points.
- In their last fiscal years Cigna kept 2.2% of revenue as net income and NeoGenomics Laboratories, Inc. -14.9%.
- In the last 90 days insiders reported 0 open-market purchases at Cigna and 0 at NeoGenomics Laboratories, Inc.; members of Congress disclosed 0 trades in Cigna and 1 in NeoGenomics Laboratories, Inc..
- Next results: Cigna Feb 4, 2027, NeoGenomics Laboratories, Inc. Feb 15, 2027.
How each one makes money: NeoGenomics Laboratories, Inc. revenue
Share prices on one chart
Cigna and NeoGenomics Laboratories, Inc., and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Cigna CINYSE · Health Care Services | NeoGenomics Laboratories, Inc. NEONASDAQ · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $71.4B | $1.92B |
| Revenue, last fiscal year | $275B | $727M |
| Net income, last fiscal year | $5.96B | −$108M |
| Net marginNet income as a share of revenue | 2.2% | -14.9% |
| Free cash flow | $9.6B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Common questions
How is Cigna different from NeoGenomics Laboratories, Inc.?
Cigna (CI) is in Health Care Services on NYSE, with $275B of revenue in its last fiscal year and a net margin of 2.2%. NeoGenomics Laboratories, Inc. (NEO) is in Health Care Services on NASDAQ, with $727M of revenue in its last fiscal year and a net margin of -14.9%. The biggest part of NeoGenomics Laboratories, Inc.'s revenue is Client direct billing, 71% of the total in its last annual report. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Cigna and NeoGenomics Laboratories, Inc. compare in size?
Cigna has the larger market value: Cigna $71.4B and NeoGenomics Laboratories, Inc. $1.92B, at the last close.
Whose share price rose more over the last 12 months, CI or NEO?
Over the last 12 months Cigna moved +0.5% and NeoGenomics Laboratories, Inc. +39.8%. Past price moves say nothing about the future.
Which has had more insider buying, Cigna or NeoGenomics Laboratories, Inc.?
Since 2006, NeoGenomics Laboratories, Inc. insiders reported 38 open-market purchases against 9 for Cigna. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CI or NEO?
In the last 12 months, members of Congress disclosed 14 trades in Cigna (CI) and 1 in NeoGenomics Laboratories, Inc. (NEO).
When did insiders last buy CI and NEO?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Cigna pageNeoGenomics Laboratories, Inc. pageRare insider trades this weekAll comparisons
https://oqro.io/compare/ci-vs-neo




